Peptide Profiles
Independent, research-based profiles of individual peptides: what they are, how they are studied, and their current regulatory status.
BPC-157: What the Research Looks At
An education-first look at BPC-157: what it is, how it is studied, and its current US regulatory status. Not medical advice.
CJC-1295: What the Research Looks At
An education-first look at CJC-1295: what it is, how the DAC and non-DAC variants differ, and its regulatory status. Not medical advice.
GHK-Cu: What the Research Looks At
An education-first look at GHK-Cu copper peptide: what it is, how it is studied, and how skin and injectable use differ. Not medical advice.
Ipamorelin: What the Research Looks At
An education-first look at ipamorelin: what it is, how it is studied, and its current US regulatory status. Not medical advice.
NAD+ Therapy: What the Research Looks At
An education-first look at NAD+ therapy: what it is, how IV and precursor forms differ, and its regulatory status. Not medical advice.
Semaglutide: What the Research Looks At
An education-first look at semaglutide: what it is, its approved uses, and how it differs from research-only peptides. Not medical advice.
Sermorelin: What the Research Looks At
An education-first look at sermorelin: its history as an approved product, current compounded use, and regulatory status. Not medical advice.
TB-500: What the Research Looks At
An education-first look at TB-500: what it is, how it is studied, and its current US regulatory status. Not medical advice.
Tesamorelin: What the Research Looks At
An education-first look at tesamorelin: what it is, its one approved use, and how compounded versions differ. Not medical advice.
Tirzepatide: What the Research Looks At
An education-first look at tirzepatide: what it is, its approved uses, and how it differs from research-only peptides. Not medical advice.